title: Clinical responses to gefinitib after failure of treatment with cetuximab in advanced non-small-cell lung cancer.
authors.forename: Luis E
authors.initials: LE
authors.lastname: Raez
authors.forename: Gilberto
authors.initials: G
authors.lastname: Lopes
authors.forename: Rogerio
authors.initials: R
authors.lastname: Lilenbaum
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D000068818:Cetuximab; D005260:Female; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011799:Quinazolines / Q000627:therapeutic use*; D017211:Treatment Failure
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D011799:Quinazolines; D000068818:Cetuximab; D000077156:Gefitinib